Related references
Note: Only part of the references are listed.Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch® system and the CellCelector
Martin Horst Dieter Neumann et al.
BIOTECHNOLOGY PROGRESS (2017)
Circulating tumor cells: clinical validity and utility
Luc Cabel et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
The impact of heterogeneity in phosphoinositide 3-kinase pathway in human cancer and possible therapeutic treatments
William Wang et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
Katherine E. Poruk et al.
ANNALS OF SURGERY (2016)
Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
Sara Jansson et al.
BMC CANCER (2016)
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer
Thomas M. Deutsch et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Circulating tumor cells in breast cancer-current status and perspectives
Malgorzata Banys-Paluchowski et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells
G. E. Hvichia et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer
Christin Gasch et al.
MOLECULAR ONCOLOGY (2016)
Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer
Ebubekir Dirican et al.
TUMOR BIOLOGY (2016)
Circulating tumour cell-derived plastin3 is a novel marker for predicting long-term prognosis in patients with breast cancer
H. Ueo et al.
BRITISH JOURNAL OF CANCER (2015)
The isolation and characterization of CTC subsets related to breast cancer dormancy
Monika Vishnoi et al.
SCIENTIFIC REPORTS (2015)
The detection of EpCAM+ and EpCAM- circulating tumor cells
Sanne de Wit et al.
SCIENTIFIC REPORTS (2015)
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
Marta Pestrin et al.
MOLECULAR ONCOLOGY (2015)
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation
Lei Xu et al.
PLOS ONE (2015)
EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
Helen Schneck et al.
PLOS ONE (2015)
PI3K mutations in breast cancer: prognostic and therapeutic implications
Toru Mukohara
BREAST CANCER-TARGETS AND THERAPY (2015)
PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer
Athina Markou et al.
CLINICAL CANCER RESEARCH (2014)
Molecular profiling of single circulating tumor cells with diagnostic intention
Bernhard Polzer et al.
EMBO MOLECULAR MEDICINE (2014)
Technologies for detection of circulating tumor cells: facts and vision
Catherine Alix-Panabieres et al.
LAB ON A CHIP (2014)
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
Francois-Clement Bidard et al.
LANCET ONCOLOGY (2014)
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
Maryam B. Lustberg et al.
BREAST CANCER RESEARCH (2014)
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy
Maria Spiliotaki et al.
BREAST CANCER RESEARCH (2014)
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
M. Cizkova et al.
BRITISH JOURNAL OF CANCER (2013)
Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
Takehiko Yokobori et al.
CANCER RESEARCH (2013)
Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer
A. M. Gonzalez-Angulo et al.
CANCER TREATMENT REVIEWS (2013)
Circulating tumor cells in breast cancer
Malgorzata Banys et al.
CLINICA CHIMICA ACTA (2013)
Apoptotic Circulating Tumor Cells in Early and Metastatic Breast Cancer Patients
Galatea Kallergi et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients
Helen Schneck et al.
MOLECULAR ONCOLOGY (2013)
PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
Sherene Loi et al.
PLOS ONE (2013)
Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
Ariella B. Hanker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Targeting PI3K in cancer: any good news?
Miriam Martini et al.
FRONTIERS IN ONCOLOGY (2013)
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
Tobias M. Gorges et al.
BMC CANCER (2012)
Plasticity of disseminating cancer cells in patients with epithelial malignancies
Natalia Bednarz-Knoll et al.
CANCER AND METASTASIS REVIEWS (2012)
Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
Liling Zhang et al.
CLINICAL CANCER RESEARCH (2012)
Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation
Michal Mego et al.
JOURNAL OF CANCER (2012)
PIK3CA mutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
Magdalena Cizkova et al.
BREAST CANCER RESEARCH (2012)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines
Y. Kataoka et al.
ANNALS OF ONCOLOGY (2010)
Development and Optimization of a Process for Automated Recovery of Single Cells Identified by Microengraving
Jae Hyeok Choi et al.
BIOTECHNOLOGY PROGRESS (2010)
M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis
Elisabetta Rossi et al.
CLINICAL CANCER RESEARCH (2010)
Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors
Jannik N. Andersen et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data
Howard I. Scher et al.
LANCET ONCOLOGY (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
Antoinette Hollestelle et al.
MOLECULAR CANCER RESEARCH (2007)
Cancer-specific mutations in PIK3CA are oncogenic in vivo
AG Bader et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells
JJ Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
